Crossmark

N6-methyladenosine-modification of USP15 regulates chemotherapy resistance by inhibiting LGALS3 ubiquitin-mediated degradation via AKT/mTOR signaling activation pathway in hepatocellular carcinoma

Crossref DOI link: https://doi.org/10.1038/s41420-024-02282-y

Published Online: 2025-01-10

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Fang, Ronghuan

Jia, Zhigang

Xin, Yuhang

Zhao, Kai

Qin, Wei

Lu, Haoran

Zhou, Yi

Yang, Yongsheng https://orcid.org/0009-0002-6809-9951
Fang, He
License Information

Text and Data Mining valid from 2025-01-10

Version of Record valid from 2025-01-10
More Information

Article History

Received: 26 August 2024

Revised: 11 December 2024

Accepted: 23 December 2024

First Online: 10 January 2025

Competing interests

: The authors declare no competing interests.

: All human samples involved in this study were reviewed and approved by the Ethics Committee of the Second Hospital of Jilin University. Animal studies were reviewed and approved by the Animal Ethics Committee of Changchun Weishi Testing Technology Service Co., Ltd.

: Not applicable.

Document is current

Any future updates will be listed below